Latest Period
Q1 2026
CUSIP: 03940C100
Latest Period
Q1 2026
Institutions Reporting
236
Shares (Excl. Options)
56,544,181
Price
$114.82
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 236 institutions filings for Q1 2026.
Security key
03940C100
Latest holder period
Q1 2026
13F holders
236
13D/G owners
7
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 03940C100:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 9.9% | $379,330,540 | 5,724,016 | Paradigm BioCapital Advisors LP | 31 Dec 2025 | |||
| BlackRock, Inc. | 6.4% | $228,246,406 | 3,527,220 | BlackRock, Inc. | 31 Mar 2025 | |||
| T. Rowe Price Investment Management, Inc. | 4.5% | -77% | $185,450,898 | -$552,511,601 | 2,653,848 | -75% | T. Rowe Price Investment Management, Inc. | 28 Feb 2026 |
| PERCEPTIVE ADVISORS LLC | 4.5% | -16% | $162,432,900 | -$29,397,733 | 2,478,000 | -15% | Perceptive Advisors LLC | 30 Jun 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 2.2% | $83,974,428 | 1,267,156 | RA Capital Management, L.P. | 31 Dec 2025 | |||
| FMR LLC | 0.5% | -95% | $21,601,128 | -$227,432,217 | 309,117 | -91% | FMR LLC | 27 Feb 2026 |
| GILEAD SCIENCES, INC. | 100% | +738% | $11,482 | -$771,671,118 | 100 | -100% | GILEAD SCIENCES, INC. | 28 Apr 2026 |
As of 31 Mar 2026, 236 institutional investors reported holding 56,544,181 shares of Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX). This represents 56544181% of the company’s total 100 outstanding shares.
The largest institutional shareholders of Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX) together control 47406512% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 6720803% | 6,720,803 | 0% | 36% | $771,682,600 |
| Paradigm Biocapital Advisors LP | 5774016% | 5,774,016 | +0.87% | 14% | $662,972,517 |
| BlackRock, Inc. | 3945238% | 3,945,238 | +11% | 0.01% | $452,992,229 |
| NEA Management Company, LLC | 3045262% | 3,045,262 | 0% | 20% | $349,656,983 |
| Pentwater Capital Management LP | 2870000% | 2,870,000 | 2.3% | $329,533,400 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2425218% | 2,425,218 | 0% | 0.01% | $278,463,531 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2424818% | 2,424,818 | 0% | 0.01% | $278,417,603 |
| SR One Capital Management, LP | 2346630% | 2,346,630 | 0% | 29% | $269,440,057 |
| FIL Ltd | 2339192% | 2,339,192 | 0.21% | $268,586,025 | |
| HBK INVESTMENTS L P | 2278517% | 2,278,517 | 3.3% | $261,619,322 | |
| T. Rowe Price Investment Management, Inc. | 2255878% | 2,255,878 | -79% | 0.18% | $259,020,000 |
| STATE STREET CORP | 1675895% | 1,675,895 | -16% | 0.01% | $192,426,264 |
| GLAZER CAPITAL, LLC | 1507128% | 1,507,128 | 3.7% | $173,048,000 | |
| GOLDMAN SACHS GROUP INC | 1312155% | 1,312,155 | +96% | 0.02% | $150,661,637 |
| GEODE CAPITAL MANAGEMENT, LLC | 1028666% | 1,028,666 | +7.4% | 0.01% | $118,135,702 |
| MORGAN STANLEY | 925813% | 925,813 | +79% | 0.01% | $106,301,939 |
| JPMORGAN CHASE & CO | 593573% | 593,573 | -59% | 0% | $68,124,374 |
| Davidson Kempner Capital Management LP | 559644% | 559,644 | 1.4% | $64,258,324 | |
| ALLIANCEBERNSTEIN L.P. | 544227% | 544,227 | +1234% | 0.01% | $35,483,600 |
| TIG Advisors, LLC | 541378% | 541,378 | 3% | $62,161,022 | |
| MILLENNIUM MANAGEMENT LLC | 502846% | 502,846 | +5601% | 0.04% | $57,736,778 |
| Balyasny Asset Management L.P. | 479763% | 479,763 | 0.11% | $55,086,388 | |
| TUDOR INVESTMENT CORP ET AL | 462588% | 462,588 | +905% | 0.29% | $53,114,354 |
| BANK OF AMERICA CORP /DE/ | 452333% | 452,333 | +5.7% | 0% | $51,936,876 |
| Magnetar Financial LLC | 394931% | 394,931 | 0.46% | $45,345,977 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 56,544,181 | $6,462,814,883 | -$796,679,043 | $114.82 | 236 |
| 2025 Q4 | 66,618,317 | $4,343,543,285 | +$191,098,400 | $65.20 | 217 |
| 2025 Q3 | 63,039,877 | $5,175,204,679 | +$190,810,895 | $82.10 | 207 |
| 2025 Q2 | 60,837,024 | $4,006,426,303 | -$46,745,437 | $65.85 | 200 |
| 2025 Q1 | 61,569,105 | $4,042,657,536 | +$146,759,811 | $65.60 | 195 |
| 2024 Q4 | 59,173,488 | $4,537,933,690 | +$127,885,655 | $76.69 | 208 |
| 2024 Q3 | 49,489,073 | $4,134,912,072 | -$113,389,722 | $83.51 | 185 |
| 2024 Q2 | 50,216,931 | $2,771,120,513 | +$171,282,810 | $55.19 | 164 |
| 2024 Q1 | 47,012,321 | $3,269,162,577 | +$35,796,177 | $69.55 | 180 |
| 2023 Q4 | 46,737,558 | $2,593,995,956 | -$29,980,183 | $55.50 | 154 |
| 2023 Q3 | 47,577,643 | $1,707,089,455 | -$7,341,800 | $35.88 | 132 |
| 2023 Q2 | 48,066,751 | $1,519,832,876 | +$79,444,997 | $31.62 | 134 |
| 2023 Q1 | 45,593,955 | $1,403,613,948 | +$114,227,065 | $30.81 | 115 |
| 2022 Q4 | 41,987,329 | $1,300,761,660 | +$53,764,127 | $30.98 | 123 |
| 2022 Q3 | 41,706,487 | $782,853,521 | +$127,574,774 | $18.77 | 74 |
| 2022 Q2 | 34,934,000 | $621,506,000 | +$145,615,758 | $18.08 | 67 |
| 2022 Q1 | 26,872,990 | $357,855,000 | +$357,824,000 | $14.02 | 48 |